Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography

World Journal of Gastroenterology

Volumn 12, Issue 39, 2006, Pages 6290-6298

  Numata, Kazushi ^a   Isozaki, Tetsuo ^a   Morimoto, Manabu ^a   Sugimori, Kazuya ^a   Kunisaki, Reiko ^a   Morizane, Toshio ^b   Tanaka, Katsuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Contrast enhanced sonography; Hemangioma; Hepatocellular carcinoma; Metastasis

Indexed keywords

CONTRAST MEDIUM; GALACTOSE; PALMITIC ACID; SHU 508;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER TUMOR; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

EID: 33750834252     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i39.6290     Document Type: Article

References (30)

1. Blomley MJ, Albrecht T, Cosgrove DO, Patel N, Jayaram V, Butler-Barnes J, Eckersley RJ, Bauer A, Schlief R. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210: 409-416
2. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000; 215: 153-161
3. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216: 411-417
4. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35: 58-71
5. Numata K, Tanaka K, Kiba. T, Saito S, Ikeda M, Hara K, Tanaka N, Morimoto M, Iwase S, Sekihara H. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001; 20: 89-98
6. Ding H, Kudo M, Onda. H, Suetomi Y, Minami Y, Chung H, Kawasaki T, Maekawa K. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221: 721-730
7. Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F. Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 2001; 177: 799-805
8. Numata K, Tanaka K, Kiba T, Saito S, Isozaki T, Hara K, Morimoto M, Sekihara H, Yonezawa H, Kubota T. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR Am J Roentgenol 2001; 176: 1199-1205
9. Albrecht T, Hoffmann CW, Schmitz SA, Schettler S, Overberg A, Germer CT, Wolf KJ. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001; 176:1191-1198
10. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222: 95-102
11. Numata K, Isozaki T, Ozawa Y, Sakaguchi T, Kiba T, Kubota T, Ito A, Sugimori K, Shirato K, Morimoto M, Tanaka K. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180: 143-149
12. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11: 1316-1328
13. Kim EA, Yoon KH, Lee YH, Kim HW, Juhng SK, Won JJ. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent. Korean J Radiol 2003; 4: 224-233
14. Wen YL, Kudo M, Zheng RQ, Ding H, Zhou P, Minami Y, Chung H, Kitano M, Kawasaki T, Maekawa K. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004; 182: 1019-1026
15. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53: 401-405
16. Luo BM, Wen YL, Yang HY, Zhi H, Ou B, Ma JH, Pan JS, Dai XN. Differentiation between malignant and benign nodules in the liver: use of contrast C3-MODE technology. World J Gastroenterol 2005; 11: 2402-2407
17. von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-1568
18. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420-430
19. Peschl R, Werle A, Mathis G. Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer. Dig Dis 2004; 22: 73-80
20. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004, 24: 921-935
21. Ding H, Wang WP, Huang BJ, Wei RX, He NA, Qi Q, Li CL. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005; 24: 285-297
22. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186: 1401-1412
23. Isozaki T, Numata K, Kiba T, Hara K, Morimoto M, Sakaguchi T, Sekihara H, Kubota T, Shimada H, Morizane T, Tanaka K. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003; 229: 798-805
24. Kanai T, Hirohashi S, Upton MP, Noguchi MP, Kishi K, Makuuchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama N. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987; 60: 810-819
25. Degoulet P, Fieschi M. Medical decision support systems. In: Degoulet P, Fieschi M eds. Introduction to clinical informatics. New York: Springer-Verlag, 1997: 153-168
26. McLoughlin MJ. Angiography in cavernous hemangioma of the liver. Am J Roentgenol Radium Ther Nucl Med 1971; 113: 50-55
27. Kido, C, Sasaki T, Kaneko M. Angiography of primary liver cancer. Am J Roentgenol Radium Ther Nucl Med 1971; 113: 70-81
28. Nicolau C, Catala V, Vilana R, Gilabert R, Bianchi L, Sole M, Pages M, Bru C. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-1099
29. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
30. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236